Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma
Tumor-intrinsic adaptations with emerging resistant clones following T cell-targeted immunotherapies pose a major barrier to durable remissions in multiple myeloma. Through integrated genomic, transcriptomic and epigenomic interrogation of clonal plasma cells, we observed antigenic drift in 68.4% of...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
March 2026
|
| In: |
Nature medicine
Year: 2026, Jahrgang: 32, Heft: 3, Pages: 964-977 |
| ISSN: | 1546-170X |
| DOI: | 10.1038/s41591-025-04175-8 |
| Online-Zugang: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.1038/s41591-025-04175-8 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41591-025-04175-8 |
| Verfasserangaben: | Holly Lee, Sungwoo Ahn, Gerone A. Gonzales, Noemie Leblay, Elie Barakat, Dylan Greening, Pina Colarusso, Johnathan Canton, Sacha Benaoudia, Elham Hasheminasabgorji, Mansour Poorebrahim, David Jung, Marietta Truger, Jihong Jeong, Christine Riedhammer, Hermann Einsele, K. Martin Kortüm, Jan Eckmann, Jitka Somandin, Sara-Sheena Engel, Lawrence H. Boise, Jan Hendrik Frenking, Niels Weinhold, Konstantina Taouxi, Efstathios Kastritis, Sheri Skerget, Deeksha Vishwamitra, Yunje Cho, Francesco Maura, Marc S. Raab, Jill Corre, Leo Rasche, Hervé Avet-Loiseau, Paola Neri & Nizar J. Bahlis |
| Zusammenfassung: | Tumor-intrinsic adaptations with emerging resistant clones following T cell-targeted immunotherapies pose a major barrier to durable remissions in multiple myeloma. Through integrated genomic, transcriptomic and epigenomic interrogation of clonal plasma cells, we observed antigenic drift in 68.4% of relapsed cases following anti-GPRC5D T cell-engager (TCE) therapy (n = 21). These escape events were driven by three distinct mutational mechanisms involving (1) focal to large biallelic deletions at the GPRC5D gene locus; (2) monoallelic deletion coupled with GPRC5D single-nucleotide variants or insertions/deletions (indels) on the remaining allele; as well as (3) epigenetic GPRC5D promoter/enhancer silencing. Beyond biallelic deletions resulting in complete antigenic loss, we demonstrate that GPRC5D single-nucleotide variants and indels mutate anti-GPRC5D TCE-binding epitopes or more commonly affect G-protein-coupled receptor family conserved motifs critical for protein membrane trafficking resulting in endoplasmic reticulum GPRC5D trapping. Multiple subclones bearing distinct genomic alterations at GPRC5D locus co-emerged within individual cases, depicting their convergent evolutionary trajectories. Of note, anti-GPRC5D TCEs with varying epitope specificity, affinity and valency differentially targeted mutant subclones, underscoring their nonredundant functional roles in overcoming resistance. |
|---|---|
| Beschreibung: | Online verfügbar: 15. Januar 2026 Gesehen am 19.05.2026 |
| Beschreibung: | Online Resource |
| ISSN: | 1546-170X |
| DOI: | 10.1038/s41591-025-04175-8 |